Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1043 of 1,261

  1. US 7479272

    Method of administering and using VEGF inhibitors for the treatment of breast cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  2. US 7479273

    Method of administering and using VEGF inhibitors for the treatment of renal cell cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  3. US 7479280

    Virus-like particles for the induction of autoantibodies

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  4. US 7479579

    Triple transgenic mouse model of Alzheimer's disease

    The Regents of the University of California · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  5. US 7479562

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  6. US 7479550

    Amyloid β gene vaccines

    The Board of Regents of the University of Texas System · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  7. US 7479551

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  8. US 7479275

    Method of administering and using VEGF inhibitors for the treatment of colorectal cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  9. EP 2014653

    Neue Dicarbonsäurederivate als S1P1 Rezeptor Agonisten

    BIOPROJET SOC CIV [FR] · Granted Jan 14, 2009 · Expires Jan 9, 2029

    granted

  10. US 7476382

    Reovirus for the treatment of neoplasia

    ONCOLYTICS BIOTECH INC. · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  11. US 7476682

    N-substituted piperidine derivatives as serotonin receptor agents

    ACADIA Pharmaceuticals Inc. · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  12. US 7476257

    Methods to engineer stratified cartilage tissue

    The Regents of the University of California · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  13. US 7476535

    TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  14. US 7476402

    Methods and compositions for deterring abuse of opioid containing dosage forms

    Acurx Pharmaceuticals, Inc. · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  15. US 7476657

    Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments

    Takeda Pharmaceutical Company Limited · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  16. US 7476721

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  17. US 7473435

    Bioactive compositions form Theacea plants and processes for their production and use

    INTEGRATED BOTANICAL TECHNOLOGIES, LLC · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted

  18. US 7473780

    Drying process for preparing crystalline solid famciclovir

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted

  19. US 7473772

    Chimeric GB virus B (GBV-B)

    The Board of Regents of the University of Texas System · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted

  20. US 7473525

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Europe AG · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted

  21. US 7473433

    Pulmonary delivery of polyene antifungal agents

    Nektar Therapeutics · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted

  22. US 7470775

    Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  23. US 7470660

    Treatment for dark adaptation

    The Regents of the University of California · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  24. US 7470420

    Optical determination of glucose utilizing boronic acid adducts

    The Regents of the University of California · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.